Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SNYNF crawled date : 2022 - 03 - 29 save search
Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older
Published: 2022-03-29 (Crawled : 18:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 1.35%
H: 0.15%
C: -2.33%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 1.83%
H: 3.58%
C: 1.77%
covid-19 authorization vaccine order emergency use authorization
Sanofi Commits Potential $6B to IGM (Antibodies) in New Collab
Published: 2022-03-29 (Crawled : 13:20) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
potential sanofi antibody
Lannett Initiates Pivotal Clinical Trial For Biosimilar Insulin Glargine
Published: 2022-03-29 (Crawled : 12:00) - biospace.com/
LCI | $0.6855 0.0% 19K
|
Health Technology
|
| O: -2.51%
H: 9.62%
C: 5.76%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
trial insulin glargine biosimilar lantus
IGM Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-29 (Crawled : 11:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
IGMS | $7.95 3.25% 3.14% 690K
|
Health Technology
|
| O: 42.23%
H: 68.76%
C: 38.32%
results
Press Release: Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets
Published: 2022-03-29 (Crawled : 09:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
IGMS | $7.95 3.25% 3.14% 690K
|
Health Technology
|
| O: 42.23%
H: 68.76%
C: 38.32%
collaboration immunology
XNK Therapeutics raises SEK 132 million to accelerate growth
Published: 2022-03-29 (Crawled : 07:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
therapeutics growth
IGM Biosciences to Host Conference Call and Webcast Today to Discuss Global Collaboration Agreement with Sanofi
Published: 2022-03-29 (Crawled : 07:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
IGMS | $7.95 3.25% 3.14% 690K
|
Health Technology
|
| O: 42.23%
H: 68.76%
C: 38.32%
conference collaboration
Civica is Rallying Leaders to Make Insulin Affordable by 2024
Published: 2022-03-29 (Crawled : 05:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
insulin
Press Release: Sanofi continues on path to industry leadership in Immunology with Dupixent® (dupilumab) as key driver
Published: 2022-03-29 (Crawled : 02:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.12%
H: 0.93%
C: 0.85%
dupixent immunology
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.